Ny diabetes mellitus, hyperglykæmi eller exacerbation af eksisterende diabetes mellitus er rapporteret hos patienter som fik proteasehæmmere.
New onset diabetes mellitus, hyperglycaemia or exacerbation of existing diabetes mellitus has been reported in patients receiving protease inhibitors.